Complete Response Letters

Salamandra, LLC: rosuvastatin

What FDA's Complete Response Letters to the company say, in the letters' own words.

EphemerisX Research · Sep 30, 2026 · Sources: FDA, SEC

Complete Response Letter, Jun 22, 2016

Satisfactory resolution of these deficiencies is required before this application may be approved.

Complete Response Letter · Jun 22, 2016 · p. 2Open the letter at p. 2 ↗CRL_NDA208647_20160622:p1:s22

Updated Sep 30, 2026 · built from 283 companies in the EphemerisX knowledge graph. This page is regenerated as companies are added.